Description
The majority of cancers initially respond very well to standard of care chemotherapeutics but invariably become resistant leading to cancer relapse and patient mortality. This project seeks to identify novel therapeutic targets that will synergise resensitize tumours to chemotherapies in the resistant setting.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
chemotherapy, cancer treatment, drug targets, screen, genetics
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Molecular and Translational Sciences
Available options
PhD/Doctorate
Masters by research
Honours
Time commitment
Full-time
Top-up scholarship funding available
Yes
Year 1:
$10000
Physical location
Monash Health Translation Precinct (Monash Medical Centre)